Related Experiment Video

Updated: Jun 2, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Anticoagulation in the management of non-ST-segment elevation acute coronary syndrome

Paul P Dobesh1, Toby C Trujillo

  • 1College of Pharmacy, University of Nebraska, Omaha, NE 68198, USA. pdobesh@unmc.edu

Journal of Pharmacy Practice
|April 22, 2011
PubMed

Insights

Managing non-ST-segment elevation acute coronary syndrome (NSTE ACS) requires careful use of anticoagulant and antiplatelet therapies. This review evaluates current guidelines and literature for optimal NSTE ACS treatment strategies.

Area of Science:

  • Cardiology
  • Pharmacology
  • Internal Medicine

Background:

  • Non-ST-segment elevation acute coronary syndrome (NSTE ACS) affects over 1 million US hospital admissions annually.
  • Significant morbidity and mortality underscore the need for optimal medication use in NSTE ACS.
  • Atherosclerotic plaque rupture and thrombus formation are key pathophysiologic processes in NSTE ACS.

Purpose of the Study:

  • To evaluate current consensus guidelines for anticoagulant therapy in NSTE ACS.
  • To critically analyze the literature regarding anticoagulant use in NSTE ACS.
  • To provide insights for implementing effective anticoagulant strategies in NSTE ACS patient protocols.

Main Methods:

  • Review of current NSTE ACS management guidelines.
  • Critical analysis of published literature on anticoagulant agents for NSTE ACS.
  • Examination of institutional treatment philosophies and approaches.

Main Results:

  • Identification of various available anticoagulant agents for NSTE ACS.
  • Assessment of evidence supporting different anticoagulant therapies.
  • Consideration of factors influencing anticoagulant selection in NSTE ACS.

Conclusions:

  • In-depth knowledge of anticoagulant agents, guidelines, and institutional practices is crucial for NSTE ACS management.
  • Appropriate selection and combination of antiplatelet and anticoagulant therapy are vital for optimal patient outcomes.
  • This review aids clinicians in making informed decisions regarding anticoagulant implementation in NSTE ACS protocols.

More Related Videos

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...